Company Filing History:
Years Active: 2021-2025
Title: Innovations by Reinier Hernandez
Introduction
Reinier Hernandez is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of theranostics, particularly in the development of PSMA-targeting ligands. With a total of 4 patents to his name, his work is paving the way for advancements in cancer detection and treatment.
Latest Patents
Hernandez's latest patents focus on PSMA-targeting ligands with optimal properties for imaging and therapy. These theranostic agents incorporate a chelating moiety that can chelate a radioactive metal isotope alongside a PSMA-targeting moiety. The agents are designed to treat and detect cancers associated with increased PSMA expression. The formula includes complexes, anions, or salts thereof, where R includes a chelating moiety, and the parameters a and n define specific characteristics of the ligands. The chelating moiety may also be linked to a metal atom, which can be a positron or single photon emitting metal isotope, or an alpha, beta, or Auger emitting metal isotope.
Career Highlights
Reinier Hernandez is affiliated with the Wisconsin Alumni Research Foundation, where he continues to innovate in the field of medical imaging and therapy. His work is instrumental in developing new methods for cancer treatment, showcasing his commitment to improving healthcare outcomes.
Collaborations
Hernandez collaborates with esteemed colleagues such as Anatoly Pinchuk and Jamey Paul Weichert. These partnerships enhance the research and development of innovative solutions in the medical field.
Conclusion
Reinier Hernandez is a prominent inventor whose work in PSMA-targeting ligands is making a significant impact in cancer therapy and imaging. His contributions are vital to the ongoing advancements in medical technology and treatment options.